Abstract
Elucidating the regulation of glucose-stimulated insulin secretion (GSIS) in pancreatic β cells is important for understanding and treating diabetes. The pancreatic β cell line, MIN6, retains GSIS but gradually loses it in long-term culture. The MIN6 subclone, MIN6c4, exhibits well-regulated GSIS even after prolonged culture. We previously used DNA microarray analysis to compare gene expression in the parental MIN6 cells and MIN6c4 cells and identified several differentially regulated genes that may be involved in maintaining GSIS. Here we investigated the potential roles of six of these genes in GSIS: Tmem59l (Transmembrane protein 59 like), Scgn (Secretagogin), Gucy2c (Guanylate cyclase 2c), Slc29a4 (Solute carrier family 29, member 4), Cdhr1 (Cadherin-related family member 1), and Celsr2 (Cadherin EGF LAG seven-pass G-type receptor 2). These genes were knocked down in MIN6c4 cells using lentivirus vectors expressing gene-specific short hairpin RNAs (shRNAs), and the effects of the knockdown on insulin expression and secretion were analyzed. Suppression of Tmem59l, Scgn, and Gucy2c expression resulted in significantly decreased glucose- and/or KCl-stimulated insulin secretion from MIN6c4 cells, while the suppression of Slc29a4 expression resulted in increased insulin secretion. Tmem59l overexpression rescued the phenotype of the Tmem59l knockdown MIN6c4 cells, and immunostaining analysis indicated that the TMEM59L protein colocalized with insulin and GM130, a Golgi complex marker, in MIN6 cells. Collectively, our findings suggested that the proteins encoded by Tmem59l, Scgn, Gucy2c, and Slc29a4 play important roles in regulating GSIS. Detailed studies of these proteins and their functions are expected to provide new insights into the molecular mechanisms involved in insulin secretion.
Highlights
Glucose-stimulated insulin secretion (GSIS) from pancreatic β cells is essential for the regulation of blood glucose levels
We identified a group of genes whose expression was high in the glucose-responsive parental MIN6 cells at low passage (Pr-LP), C4-LP, and C4-HP cells, but was extremely low in the nonresponsive Pr-HP cells, as candidate genes that may be involved in the maintenance of GSIS [4]
Scgn was expressed in the islets, but not in the brain. The expression of these genes was not detected in the whole pancreas in this experiment, suggesting that their expression was probably restricted to the islets
Summary
Glucose-stimulated insulin secretion (GSIS) from pancreatic β cells is essential for the regulation of blood glucose levels. Novel Regulators of Insulin Secretion underlying mechanisms have not been fully elucidated. The first-phase insulin release begins soon after the glucose stimulation and persists only for a few min and is followed by the second phase, which lasts for 2–3 h. This biphasic pattern is observed in vivo and in vitro. In the pathogenesis of type 2 diabetes, the earliest detectable defect in β-cell function is generally thought to be a reduction in first-phase insulin secretion [2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.